QTc prolongation and diabetes therapies

Diabet Med. 2012 Mar;29(3):290-2. doi: 10.1111/j.1464-5491.2011.03520.x.
No abstract available

MeSH terms

  • Anti-Arrhythmia Agents / adverse effects*
  • Diabetes Mellitus, Type 1 / complications*
  • Diabetes Mellitus, Type 1 / drug therapy
  • Diabetes Mellitus, Type 2 / complications*
  • Diabetes Mellitus, Type 2 / drug therapy
  • Diabetic Angiopathies / chemically induced
  • Diabetic Angiopathies / etiology*
  • Electrocardiography
  • Humans
  • Long QT Syndrome / chemically induced
  • Long QT Syndrome / etiology*
  • Risk Factors
  • Vasodilator Agents / adverse effects*

Substances

  • Anti-Arrhythmia Agents
  • Vasodilator Agents